Evaluating the Effectiveness of 25 Popular Acute Migraine Medications

Study on medications used by migraine buddy users

Migraine is a draining condition that affects millions of people worldwide. There are numerous acute treatment options available, but there is a lack of large-scale, head-to-head comparisons of their effectiveness based on real-world patient reports. However, a recent study analyzed the records of 10 million migraine attacks from Migraine Buddy to compare the effectiveness of 25 acute migraine medications.

The study included 10 million migraine attack records from the e-diary between June 2014 and July 2020. The researchers analyzed 25 acute medications, including acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), triptans, combination analgesics, ergots, antiemetics, and opioids. The analysis revealed that triptans, ergots, and antiemetics were the most effective classes of medications for migraine treatment. These findings align with guideline recommendations and offer valuable insights for clinical practice.

The study also compared the effectiveness of individual medications within each class. The top three medications with the highest odds of effectiveness were eletriptan, zolmitriptan, and sumatriptan. On the other hand, acetaminophen, NSAIDs, combination analgesics, and opioids were found to have similar or lower reported effectiveness compared to ibuprofen.

Overall, this study provides valuable insights into the effectiveness of different acute migraine medications based on real-world patient reports. The findings can help healthcare professionals make informed treatment decisions and provide better care for individuals suffering from migraine. It is important to note that the study was based on self-reported data, and further research is needed to validate these findings. Nonetheless, this study contributes to the growing body of knowledge on migraine treatment and offers hope for improved management of migraine attacks.

Jenny from Migraine Buddy
Love

You Will Also Like

Open
Back to Blog

Leave your mobile to get a link to download the app